Rademikibart Antibody
Rademikibart (CBP-201) is a potent, species-specific human anti-IL-4Rα monoclonal antibody (KD = 20.7 pM) . It effectively blocks IL-4/IL-13-induced STAT6 signaling, TF-1 cell proliferation, and TARC release, serving as a critical research tool for investigating Th2-driven pathologies like atopic dermatitis and asthma in relevant cellular and animal models.
Product Specifications
Product Name Alternative
CBP201, CBP-201
Target
IL Receptor, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.38 mg/mL
Purity
97.50% (May vary between batches)
Molecular Weight
143.54 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
20058121 3x 1.0µg DNA
FAM57B CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details MBS1451600-01 0.02 mg (E-Coli)
Recombinant Saccharophagus degradans Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1451600-02 0.1 mg (E-Coli)
Recombinant Saccharophagus degradans Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1451600-03 0.02 mg (Yeast)
Recombinant Saccharophagus degradans Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details